Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

TP53, ETV6 and RUNX1 germline variants in a case series of patients developing secondary neoplasms after treatment for childhood acute lymphoblastic leukemia.

Junk SV, Klein N, Schreek S, Zimmermann M, Möricke A, Bleckmann K, Alten J, Dagdan E, Cario G, Kratz CP, Schrappe M, Stanulla M.

Haematologica. 2019 Jul 9. pii: haematol.2018.205849. doi: 10.3324/haematol.2018.205849. [Epub ahead of print]

2.

High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.

Hoffmann J, Krumbholz M, Gutiérrez HP, Fillies M, Szymansky A, Bleckmann K, Zur Stadt U, Köhler R, Kuiper RP, Horstmann M, von Stackelberg A, Eckert C, Metzler M.

Pediatr Blood Cancer. 2019 Aug;66(8):e27780. doi: 10.1002/pbc.27780. Epub 2019 Apr 29.

PMID:
31034759
3.

International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.

Hrusak O, de Haas V, Stancikova J, Vakrmanova B, Janotova I, Mejstrikova E, Capek V, Trka J, Zaliova M, Luks A, Bleckmann K, Möricke A, Irving J, Konatkowska B, Alexander TB, Inaba H, Schmiegelow K, Stokley S, Zemanova Z, Moorman AV, Rossi JG, Felice MS, Dalla-Pozza L, Morales J, Dworzak M, Buldini B, Basso G, Campbell M, Cabrera ME, Marinov N, Elitzur S, Izraeli S, Luria D, Feuerstein T, Kolenova A, Svec P, Kreminska O, Rabin KR, Polychronopoulou S, da Costa E, Marquart HV, Kattamis A, Ratei R, Reinhardt D, Choi JK, Schrappe M, Stary J.

Blood. 2018 Jul 19;132(3):264-276. doi: 10.1182/blood-2017-12-821363. Epub 2018 May 2.

4.

Osteonecrosis in children with acute lymphoblastic leukemia at initial diagnosis and prior to any chemotherapy.

Krull K, Kunstreich M, Bronsema A, Bleckmann K, Classen CF, Erdlenbruch B, Jorch N, Kolb R, Leipold A, Moser O, Prokop A, Scheurlen W, Steinbach D, Klasen-Sansone J, Klee D, Escherich G, Moericke A, Schrappe M, Borkhardt A, Kuhlen M.

Leuk Lymphoma. 2019 Jan;60(1):78-84. doi: 10.1080/10428194.2018.1466292. Epub 2018 May 2.

PMID:
29718744
5.

IKZF1plus Defines a New Minimal Residual Disease-Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia.

Stanulla M, Dagdan E, Zaliova M, Möricke A, Palmi C, Cazzaniga G, Eckert C, Te Kronnie G, Bourquin JP, Bornhauser B, Koehler R, Bartram CR, Ludwig WD, Bleckmann K, Groeneveld-Krentz S, Schewe D, Junk SV, Hinze L, Klein N, Kratz CP, Biondi A, Borkhardt A, Kulozik A, Muckenthaler MU, Basso G, Valsecchi MG, Izraeli S, Petersen BS, Franke A, Dörge P, Steinemann D, Haas OA, Panzer-Grümayer R, Cavé H, Houlston RS, Cario G, Schrappe M, Zimmermann M; TRANSCALL Consortium; International BFM Study Group.

J Clin Oncol. 2018 Apr 20;36(12):1240-1249. doi: 10.1200/JCO.2017.74.3617. Epub 2018 Mar 2.

PMID:
29498923
6.

Reduced-Intensity Delayed Intensification in Standard-Risk Pediatric Acute Lymphoblastic Leukemia Defined by Undetectable Minimal Residual Disease: Results of an International Randomized Trial (AIEOP-BFM ALL 2000).

Schrappe M, Bleckmann K, Zimmermann M, Biondi A, Möricke A, Locatelli F, Cario G, Rizzari C, Attarbaschi A, Valsecchi MG, Bartram CR, Barisone E, Niggli F, Niemeyer C, Testi AM, Mann G, Ziino O, Schäfer B, Panzer-Grümayer R, Beier R, Parasole R, Göhring G, Ludwig WD, Casale F, Schlegel PG, Basso G, Conter V.

J Clin Oncol. 2018 Jan 20;36(3):244-253. doi: 10.1200/JCO.2017.74.4946. Epub 2017 Nov 17.

7.

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.

Cazzaniga G, De Lorenzo P, Alten J, Röttgers S, Hancock J, Saha V, Castor A, Madsen HO, Gandemer V, Cavé H, Leoni V, Köhler R, Ferrari GM, Bleckmann K, Pieters R, van der Velden V, Stary J, Zuna J, Escherich G, Stadt UZ, Aricò M, Conter V, Schrappe M, Valsecchi MG, Biondi A.

Haematologica. 2018 Jan;103(1):107-115. doi: 10.3324/haematol.2017.176917. Epub 2017 Oct 27.

8.

Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.

Kuhlen M, Bleckmann K, Möricke A, Schrappe M, Vieth S, Escherich G, Bronsema A, Vonalt A, Queudeville M, Zwaan CM, Ebinger M, Debatin KM, Klingebiel T, Koscielniak E, Rossig C, Burkhardt B, Kolb R, Eckert C, Borkhardt A, von Stackelberg A, Chen-Santel C.

Br J Haematol. 2017 Oct;179(2):272-283. doi: 10.1111/bjh.14877. Epub 2017 Aug 2.

PMID:
28771662
9.

Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.

Schmäh J, Fedders B, Panzer-Grümayer R, Fischer S, Zimmermann M, Dagdan E, Bens S, Schewe D, Moericke A, Alten J, Bleckmann K, Siebert R, Schrappe M, Stanulla M, Cario G.

Pediatr Blood Cancer. 2017 Oct;64(10). doi: 10.1002/pbc.26539. Epub 2017 Apr 1.

PMID:
28371317
10.

Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology.

Hovorkova L, Zaliova M, Venn NC, Bleckmann K, Trkova M, Potuckova E, Vaskova M, Linhartova J, Machova Polakova K, Fronkova E, Muskovic W, Giles JE, Shaw PJ, Cario G, Sutton R, Stary J, Trka J, Zuna J.

Blood. 2017 May 18;129(20):2771-2781. doi: 10.1182/blood-2016-11-749978. Epub 2017 Mar 22.

11.

Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia - first findings of the OPAL trial.

Krull K, Kunstreich M, Klasen-Sansone J, Kloetgen A, Gruener F, Escherich G, Bleckmann K, Moericke A, Schrappe M, Jorch N, Steinbach D, Classen CF, Guggemos A, Kolb R, Klee D, Borkhardt A, Kuhlen M.

Leuk Lymphoma. 2017 Oct;58(10):2363-2369. doi: 10.1080/10428194.2017.1280605. Epub 2017 Jan 31.

PMID:
28140726
12.

T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases.

Doerrenberg M, Kloetgen A, Hezaveh K, Wössmann W, Bleckmann K, Stanulla M, Schrappe M, McHardy AC, Borkhardt A, Hoell JI.

Genes Chromosomes Cancer. 2017 Feb;56(2):159-167. doi: 10.1002/gcc.22423. Epub 2016 Oct 26.

PMID:
27717083
13.

Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.

Bleckmann K, Schrappe M.

Br J Haematol. 2016 Mar;172(6):855-69. doi: 10.1111/bjh.13896. Epub 2016 Jan 15. Review.

PMID:
26773444
14.

Preexisting conditions in pediatric ALL patients: Spectrum, frequency and clinical impact.

Schütte P, Möricke A, Zimmermann M, Bleckmann K, Reismüller B, Attarbaschi A, Mann G, Bodmer N, Niggli F, Schrappe M, Stanulla M, Kratz CP.

Eur J Med Genet. 2016 Mar;59(3):143-51. doi: 10.1016/j.ejmg.2015.12.008. Epub 2015 Dec 28. Review.

PMID:
26732628
15.

Secondary histiocytic sarcoma may cause apparent persistence or recurrence of minimal residual disease in childhood acute lymphoblastic leukemia.

Alten J, Klapper W, Leuschner I, Eckert C, Beier R, Vallo E, Krause M, Claviez A, Vieth S, Bleckmann K, Möricke A, Schrappe M, Cario G.

Pediatr Blood Cancer. 2015 Sep;62(9):1656-60. doi: 10.1002/pbc.25523. Epub 2015 Apr 1. Review.

PMID:
25833113
16.

[The fate of so-called hazard children as reflected in child rearing counseling].

Bleckmann KH.

Prax Kinderpsychol Kinderpsychiatr. 1971 May-Jun;20(4):125-32. German. No abstract available.

PMID:
4104350
17.

[The fate of premature children reflected in educational counseling].

Bleckmann K.

Prax Kinderpsychol Kinderpsychiatr. 1970 Aug-Sep;19(6):227-30. German. No abstract available.

PMID:
5534456
18.

[Empirical report on the use of pyrithioxine in pediatric practice (with special reference to experience within the scope of educational advice)].

Bleckmann KH.

Prax Kinderpsychol Kinderpsychiatr. 1965 Nov-Dec;14(8):316-7. German. No abstract available.

PMID:
5330393
19.

[REPORT ON EXPERIENCES IN EDUCATIONAL GUIDANCE].

BLECKMANN KH, HEVELING T.

Prax Kinderpsychol Kinderpsychiatr. 1963 Aug-Sep;12:224-9. German. No abstract available.

PMID:
14090049
20.

[On the problem of an epoch-making change in the symptomatology of child behavior disorders].

BLECKMANN KH.

Prax Kinderpsychol Kinderpsychiatr. 1962 Nov-Dec;11:273-7. German. No abstract available.

PMID:
13971602
21.

[Significance of the evils of civilization in pediatrics].

BOSSERT O, BLECKMANN KH.

Ann Paediatr Fenn. 1957;3(4):610-6. German. No abstract available.

PMID:
13498518
22.

[Hypnotics in childhood; experiences with glutarinide as a hypnotic and sedative].

BLECKMANN KH, SALUS D.

Med Monatsschr. 1956 Mar;10(3):162-5. German. No abstract available.

PMID:
13333620
23.

[The application of megaphen in pneumoencephalography in children].

BLECKMANN KH, SALUS D.

Monatsschr Kinderheilkd. 1955 Jul;103(7):337-8. German. No abstract available.

PMID:
13265517
24.

[War-injured children and adolescents].

VILLINGER W, BOSSERT O, BLECKMANN KH.

Monatsschr Kinderheilkd. 1955 Feb;103(2):65-76. German. No abstract available.

PMID:
14383674
25.

[Mute children].

BLECKMANN KH.

Med Monatsschr. 1953 May;7(5):301-2. Undetermined Language. No abstract available.

PMID:
13086522
26.

[Diagnosis and therapy of vegetative dystonia in childhood].

BLECKMANN KH, BUCHELERES G.

Medizinische. 1952 Nov 22;20(47):1486-9. Undetermined Language. No abstract available.

PMID:
13024584
27.

[Sleep as biological and anthropological problem].

BLECKMANN KH.

Med Monatsschr. 1952 Apr;6(4):247-51. Undetermined Language. No abstract available.

PMID:
14947503
28.

[Position of the pediatrician in the guidance system for the problem child].

BLECKMANN KH.

Med Tech (Stuttg). 1952 Feb 6;5:150-1. Undetermined Language. No abstract available.

PMID:
14940519
29.

[The problem child].

BLECKMANN KH.

Med Monatsschr. 1952 Feb;6(2):81-5. Undetermined Language. No abstract available.

PMID:
14940617
30.

[The sleep of children].

BLECKMANN KH.

Med Welt. 1951 Aug 25;20(33-34):1019-24. Undetermined Language. No abstract available.

PMID:
14882065
31.

[Diagnostic significance of the blood sedimentation reaction in early childhood].

BLECKMANN KH, KUTTNER H.

Arch Kinderheilkd. 1951;141(1):12-22. Undetermined Language. No abstract available.

PMID:
14820148
32.

[Comparative studies of the blood picture during the years 1939-49].

BLECKMANN KH, KUTTNER H.

Arch Kinderheilkd. 1950;140(4):173-82. Undetermined Language. No abstract available.

PMID:
14800353
33.

Ueber Versuche mit Colifiltraten; capillarmikroskopische Beobachtungen bei intracutaner Anwendung von Colifiltraten.

BLECKMANN KH.

Z Kinderheilkd. 1949;66(3):195-213. Undetermined Language. No abstract available.

PMID:
18150693
34.

Die Bedeutung der psychophysischen Korrelation für die Praxis.

BLECKMANN KH.

Dtsch Med Rundsch. 1948 Jun;2(6):232-5. Undetermined Language. No abstract available.

PMID:
18881390
35.

Vorschläge zur Behandlung des kindlichen Ekzems.

BLECKMANN KH.

Dtsch Med Rundsch. 1948 Jun;2(6):231. Undetermined Language. No abstract available.

PMID:
18881389
36.

Supplemental Content

Loading ...
Support Center